BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Drug Development

  Amneal Reports Potential Therapeutic Step Forward for Parkinson’s Patients

  In the pivotal Phase III trial, Amneal’s investigational Parkinson’s drug, IPX-203, met its primary endpoint, demonstrating superior “Good On” time in patients with motor fluctuations.

  August 26, 2021

   · 

  2 min read

   · 

  Heather McKenzie
• 

  Business

  BioSpace Movers & Shakers, Aug. 27

  Biopharma companies and life sciences organizations strengthen their leadership teams and boards with these Movers & Shakers.

  August 26, 2021

   · 

  7 min read

   · 

  Alex Keown
• 

  Business

  Lilly and Lycia Ink Collaboration and Licensing Deal Worth Up to $1.6 Billion

  Lycia will be receiving a $35 million upfront payment from Lilly and is eligible for over $1.6 billion in potential milestone payments.

  August 26, 2021

   · 

  2 min read

   · 

  Ellen Bombela
• 

  Biotech Beach

  Research Roundup: Potential Eye Test for Alzheimer’s and More

  Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

  August 26, 2021

   · 

  5 min read

   · 

  Mark Terry
• 

  Policy

  CDC, Heat Biologics Establish New Pandemic Preparedness Initiatives

  The CDC is taking a proactive stance and establishing a center that will use forecasting and outbreak analytics to guide public health decision-making.

  August 26, 2021

   · 

  4 min read

   · 

  Alex Keown
• 

  Drug Development

  The Next Generation of Treatments for Advanced Cervical Cancer

  Approximately 14,000 American women are expected to be diagnosed with invasive cervical cancer in 2021, and more than 4,000 are expected to succumb to the disease.

  August 26, 2021

   · 

  7 min read

   · 

  Heather McKenzie
• 

  FDA

  Amid Ethics Allegations, Sesen Pulls Bladder Cancer Drug Application from Europe

  Less than 10 days after the FDA slammed Sesen bladder cancer drug with a CRL, the company has withdrawn its Marketing Application Authorization from the European Union.

  August 26, 2021

   · 

  2 min read

   · 

  Alex Keown
• 

  Drug Development

  Drug Candidate for Wilson Disease Meets Primary Endpoint in Phase III Trial

  The FoCus Phase III trial by Alexion and AstraZeneca showed that ALXN1840 demonstrated around three times greater copper mobilization from tissues than SoC treatments for Wilson disease.

  August 26, 2021

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Career Advice

  How to Practice Leadership at Work

  Leadership can be a very challenging skill, and you cannot learn it overnight. People take years learning how to perform leadership at work that can be profitable for them.

  August 26, 2021

   · 

  2 min read

   · 

  Brandi Marcene
• 

  Drug Development

  COVID-19 News: Pfizer Vaccine Associated with Increased Risk of Myocarditis and More

  As many children go back to school, new waves of COVID-19 cases continue to surge. More data keeps coming in on potential vaccine risks and how they measure up against the risk of the disease. Here’s a look.

  August 26, 2021

   · 

  3 min read

   · 

  Mark Terry